Lucid Group are shortlisted in three different categories at this year’s PMEA programme

Lucid’s talent for working together with their clients to create magical programmes is clear to see as they celebrate three of their campaigns making the 2018 PMEA finals, well as making the cut for PMEA Support Agency of Year.

Jan Steele, Lucid Group COO and Co-founder commented, “We are extremely proud of our client partnerships. By continuing to push boundaries and creating industry-leading medical communications, we have, together, been able to transform the lives of those we touch. I am thrilled that their work has been shortlisted at this year’s PMEA.”

The PMEA programme aims to recognise work that delivers clearly identifiable benefits and improved outcomes for patients. The winners will be announced at the awards ceremony on Thursday 22nd November at The Tower – A Guoman Hotel.

More details about the shortlisted campaigns can be found below:

 Excellence in Rare Diseases and Orphan Drugs:            

  • Revolutionising management of hidradenitis suppurativa in Europe: Why? What? How?
  • Advancing Science in a Rare Disease – A Cost Effective Clinical Decision Support Programme for Cystinosis.

Excellence in Healthcare Professional Education and Support Programmes:   

  • OptiMiSe: Delivering patient-centric management in MS through clinical behaviour change.

PMEA Support Agency of the Year:


Recent posts
We transform lives. Always. Get in touch to find out more.